Bayer AG Stock CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Stocks
BAYNd
DE000BAY0017
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.77 EUR | -2.96% |
|
+2.48% | -33.31% |
| 18/06 | The Gulf Gives, the Fed Takes |  |
| 18/06 | AlphaValue/Baader Europe Downgrades Bayer to Add, Lifts PT | MT |
| Market Cap | 36.5B 41.83B 33.64B 31.67B 59.11B 3,947B 59.62B 401B 155B 1,943B 157B 154B 6,743B | P/E 2026 * |
15.8x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 68.19B 78.15B 62.85B 59.18B 110B 7,375B 111B 749B 290B 3,630B 293B 287B 12,599B | EV / Sales 2026 * |
1.5x | EV / Sales 2027 * | 1.39x |
| Free-Float |
100% | Yield 2026 * |
0.6% | Yield 2027 * | 1.99% |
Last Transcript: Bayer AG
| 1 week | +2.34% | ||
| Current month | +1.41% | ||
| 1 month | -2.26% | ||
| 3 months | -6.99% | ||
| 6 months | +4.42% | ||
| Current year | -0.61% |
| 1 week | 35.59 |  | 38.58 |
| 1 month | 32.9 | | 39.46 |
| 3 years | 18.39 | | 53.79 |
| 5 years | 18.39 | | 67.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 01/06/2023 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 01/06/2026 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 01/04/2012 |
| Director/Board Member | 66 | 01/04/2022 | |
Heike Hausfeld
BRD | Director/Board Member | 60 | 01/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.96% | +2.48% | +34.76% | -29.60% | 42.98B | |
| -1.21% | -3.33% | +38.84% | +145.38% | 992B | |
| -2.48% | -4.23% | +49.88% | +39.07% | 564B | |
| -2.14% | -3.76% | +16.72% | +56.15% | 391B | |
| -1.18% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.36% | -2.30% | +23.37% | +11.59% | 280B | |
| -2.45% | -0.84% | +23.51% | +30.06% | 279B | |
| -1.91% | -1.06% | -42.60% | -49.25% | 196B | |
| -1.19% | -0.04% | +16.39% | +47.00% | 184B | |
| -1.35% | +1.88% | +14.59% | +56.94% | 156B | |
| Average | -0.81% | +0.41% | +20.01% | +32.39% | 374.58B | |
| Weighted average by Cap. | -0.48% | -0.49% | +27.19% | +62.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.54B 52.19B 41.97B 39.52B 73.76B 4,925B 74.39B 500B 194B 2,424B 196B 192B 8,414B | 46.81B 53.64B 43.14B 40.62B 75.81B 5,062B 76.46B 514B 199B 2,492B 201B 197B 8,648B |
| Net income | 2.17B 2.49B 2B 1.88B 3.52B 235B 3.55B 23.84B 9.24B 116B 9.34B 9.14B 401B | 3B 3.43B 2.76B 2.6B 4.85B 324B 4.89B 32.89B 12.74B 159B 12.89B 12.61B 554B |
| Net Debt | 31.7B 36.33B 29.21B 27.51B 51.34B 3,428B 51.78B 348B 135B 1,687B 136B 133B 5,856B | 28.63B 32.81B 26.38B 24.84B 46.36B 3,096B 46.76B 314B 122B 1,524B 123B 120B 5,289B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change |
|---|---|---|
| 18/06/26 | 36.77 € | -2.96% |
| 17/06/26 | 37.89 € | +5.37% |
| 16/06/26 | 35.96 € | -0.50% |
| 15/06/26 | 36.14 € | -0.14% |
| 12/06/26 | 36.19 € | +0.72% |
- Stock Market
- Stocks
- BAYN Stock
- BAYNd Stock
Select your edition
All financial news and data tailored to specific country editions
